Stonegate Investment Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Stonegate Investment Group's GILD Position: Q3 2025 in Review
Stonegate Investment Group increased its Gilead Sciences (GILD) stake by 2.9% in Q3 2025, buying an estimated $13.4K and bringing the position to 4,190 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #256.
Stonegate Investment Group first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. The position peaked at $591K in Q4 2023. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Stonegate Investment Group held 4,190 shares of Gilead Sciences worth $465K as of Q3 2025.
- Stonegate Investment Group bought 118 Gilead Sciences shares in Q3 2025, an estimated $13.4K.
- Gilead Sciences made up 0.01% of Stonegate Investment Group's portfolio in Q3 2025, its #256 holding.
- Stonegate Investment Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
- Stonegate Investment Group's Gilead Sciences position peaked at $591K in Q4 2023.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.